Results 261 to 270 of about 102,570 (330)

Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Fotagliptin is a novel dipeptidyl peptidase‐4 inhibitor for glycaemic control in patients with type 2 diabetes (T2D). This trial aimed to assess the efficacy and safety of fotagliptin add‐on to metformin in patients with T2D. Materials and Methods In this phase 3 randomised, double‐blind, placebo‐controlled study, patients with T2D who had
Nan Yu   +13 more
wiley   +1 more source

Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Intralesional chemotherapeutic administration represents an important treatment option for equine cutaneous neoplasia. Tigilanol‐tiglate (TT), a novel molecule extracted from Fontainea picrosperma, an Australian rainforest plant, is registered for intratumoural treatment of canine MCT, leading to rapid oncosis and tumour slough ...
Raphael Labens   +15 more
wiley   +1 more source

Incidence of fidaxomicin allergy in patients with macrolide allergies: a large database analysis. [PDF]

open access: yesAntimicrob Agents Chemother
Chiu C-Y   +4 more
europepmc   +1 more source

Roadmap of Anaphylaxis Registries Across the World

open access: yes
Clinical &Experimental Allergy, EarlyView.
Guillaume Pouessel   +8 more
wiley   +1 more source

Swiss Quality of Life and Health Care Impact Assessment in a Real‐World Erenumab‐Treated Migraine Population: Results over 2 years

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This prospective, multicenter, noninterventional cohort study evaluated the impact of erenumab on the quality of life and migraine‐related impairment of adult patients with migraine, as well as the drug's tolerability in a real‐world setting over 2 years.
Andreas R. Gantenbein   +11 more
wiley   +1 more source

Case report: Severe asthma exacerbation with steroid-induced anaphylaxis in a 30-year-old female. [PDF]

open access: yesRespir Med Case Rep
Alkhan F   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy